| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Animal: DNA Viruses |
Division of Human Gene Therapy, University of Alabama at Birmingham, Room 614, Wallace Tumor Institute, 1824 Sixth Avenue South, Birmingham, AL 35294, USA1
Author for correspondence: Ramon Alemany. Fax +1 205 975 7949. e-mail ramon.alemany{at}ccc.uab.edu
Persistence of adenovirus type 5 in blood has implications for the pathogenicity of the virus infection and for the use of this virus in oncolysis and gene therapy. In this study, the kinetics of adenovirus clearance from blood in mice has been evaluated. After a single inoculation of concentrated virus into the vena cava, virus half-life was less than 2 min. Depletion of Kupffer cells (KC) resulted in increased viraemia. After tail-vein injection, virus and latex beads co-localized within KC. An important factor in clearance by KC is the negative charge of particles. Deletion of the hexon hypervariable region 1 acidic stretch decreased the negative charge of the virion but it did not increase blood persistence. Coating with PEG (‘PEGylation’) reduced the clearance rate but also reduced infectivity.
This article has been cited by other articles:
|
|
 |
|
  R. Singh, B. Tian, and K. Kostarelos Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo FASEB J, September 1, 2008; 22(9): 3389 - 3402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. V. Shashkova, K. Doronin, J. S. Senac, and M. A. Barry Macrophage Depletion Combined with Anticoagulant Therapy Increases Therapeutic Window of Systemic Treatment with Oncolytic Adenovirus Cancer Res., July 15, 2008; 68(14): 5896 - 5904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Haisma, J. A. A. M. Kamps, G. K. Kamps, J. A. Plantinga, M. G. Rots, and A. R. Bellu Polyinosinic acid enhances delivery of adenovirus vectors in vivo by preventing sequestration in liver macrophages J. Gen. Virol., May 1, 2008; 89(5): 1097 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Qiao, H. Wang, T. Kottke, C. White, K. Twigger, R. M. Diaz, J. Thompson, P. Selby, J. de Bono, A. Melcher, et al. Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of Reovirus Clin. Cancer Res., January 1, 2008; 14(1): 259 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Stone, Y. Liu, D. Shayakhmetov, Z.-Y. Li, S. Ni, and A. Lieber Adenovirus-Platelet Interaction in Blood Causes Virus Sequestration to the Reticuloendothelial System of the Liver J. Virol., May 1, 2007; 81(9): 4866 - 4871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Othman, A. Labelle, I. Mazzetti, H. S. Elbatarny, and D. Lillicrap Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance Blood, April 1, 2007; 109(7): 2832 - 2839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Parker, S. N. Waddington, C. G. Nicol, D. M. Shayakhmetov, S. M. Buckley, L. Denby, G. Kemball-Cook, S. Ni, A. Lieber, J. H. McVey, et al. Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes Blood, October 15, 2006; 108(8): 2554 - 2561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bayo-Puxan, M. Cascallo, A. Gros, M. Huch, C. Fillat, and R. Alemany Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting J. Gen. Virol., September 1, 2006; 87(9): 2487 - 2495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jogler, D. Hoffmann, D. Theegarten, T. Grunwald, K. Uberla, and O. Wildner Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species. J. Virol., April 1, 2006; 80(7): 3549 - 3558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Linden, L. William-Olsson, A. Ahnmark, K. Ekroos, C. Hallberg, H. P. Sjogren, B. Becker, L. Svensson, J. C. Clapham, J. Oscarsson, et al. Liver-directed overexpression of mitochondrial glycerol-3-phosphate acyltransferase results in hepatic steatosis, increased triacylglycerol secretion and reduced fatty acid oxidation FASEB J, March 1, 2006; 20(3): 434 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Singh, D. Pantarotto, L. Lacerda, G. Pastorin, C. Klumpp, M. Prato, A. Bianco, and K. Kostarelos Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers PNAS, February 28, 2006; 103(9): 3357 - 3362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. P. Le, H. N. Le, I. P. Dmitriev, J. G. Davydova, T. Gavrikova, S. Yamamoto, D. T. Curiel, and M. Yamamoto Dynamic Monitoring of Oncolytic Adenovirus In Vivo by Genetic Capsid Labeling J Natl Cancer Inst, February 1, 2006; 98(3): 203 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Homicsko, A. Lukashev, and R. D. Iggo RAD001 (Everolimus) Improves the Efficacy of Replicating Adenoviruses that Target Colon Cancer Cancer Res., August 1, 2005; 65(15): 6882 - 6890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Unno, Y. Shino, F. Kondo, N. Igarashi, G. Wang, R. Shimura, T. Yamaguchi, T. Asano, H. Saisho, S. Sekiya, et al. Oncolytic Viral Therapy for Cervical and Ovarian Cancer Cells by Sindbis Virus AR339 Strain Clin. Cancer Res., June 15, 2005; 11(12): 4553 - 4560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nakamizo, F. Marini, T. Amano, A. Khan, M. Studeny, J. Gumin, J. Chen, S. Hentschel, G. Vecil, J. Dembinski, et al. Human Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Gliomas Cancer Res., April 15, 2005; 65(8): 3307 - 3318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Shayakhmetov, Z.-Y. Li, S. Ni, and A. Lieber Analysis of Adenovirus Sequestration in the Liver, Transduction of Hepatic Cells, and Innate Toxicity after Injection of Fiber-Modified Vectors J. Virol., May 15, 2004; 78(10): 5368 - 5381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Brown, C. X. Shi, S. Powell, D. Hurlbut, F. L. Graham, and D. Lillicrap Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A Blood, February 1, 2004; 103(3): 804 - 810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Koizumi, H. Mizuguchi, F. Sakurai, T. Yamaguchi, Y. Watanabe, and T. Hayakawa Reduction of Natural Adenovirus Tropism to Mouse Liver by Fiber-Shaft Exchange in Combination with both CAR- and {alpha}v Integrin-Binding Ablation J. Virol., December 15, 2003; 77(24): 13062 - 13072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Demers, D. E. Johnson, V. Tsai, S.-F. Wen, E. Quijano, T. Machemer, J. Philopena, M. Ramachandra, J. A. Howe, P. Shabram, et al. Pharmacologic Indicators of Antitumor Efficacy for Oncolytic Virotherapy Cancer Res., July 15, 2003; 63(14): 4003 - 4008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Fueyo, R. Alemany, C. Gomez-Manzano, G. N. Fuller, A. Khan, C. A. Conrad, T.-J. Liu, H. Jiang, M. G. Lemoine, K. Suzuki, et al. Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway J Natl Cancer Inst, May 7, 2003; 95(9): 652 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakamura, K. Sato, and H. Hamada Reduction of Natural Adenovirus Tropism to the Liver by both Ablation of Fiber-Coxsackievirus and Adenovirus Receptor Interaction and Use of Replaceable Short Fiber J. Virol., February 15, 2003; 77(4): 2512 - 2521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-C. Tseng, B. Levin, T. Hirano, H. Yee, C. Pampeno, and D. Meruelo In Vivo Antitumor Activity of Sindbis Viral Vectors J Natl Cancer Inst, December 4, 2002; 94(23): 1790 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Suzuki, R. Alemany, M. Yamamoto, and D. T. Curiel The Presence of the Adenovirus E3 Region Improves the Oncolytic Potency of Conditionally Replicative Adenoviruses Clin. Cancer Res., November 1, 2002; 8(11): 3348 - 3359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Einfeld, R. Schroeder, P. W. Roelvink, A. Lizonova, C. R. King, I. Kovesdi, and T. J. Wickham Reducing the Native Tropism of Adenovirus Vectors Requires Removal of both CAR and Integrin Interactions J. Virol., December 1, 2001; 75(23): 11284 - 11291. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
